Correlation Between Tumor Mesothelin Expression and Serum Mesothelin in Patients with Epithelial Ovarian Carcinoma: A Potential Noninvasive Biomarker for Mesothelin-targeted Therapy.
about
Pre-operative evaluation of circulating KL-6 levels as a biomarker for epithelial ovarian carcinoma and its correlation with tumor MUC1 expression.Amatuximab and novel agents targeting mesothelin for solid tumors.Anetumab ravtansine inhibits tumor growth and shows additive effect in combination with targeted agents and chemotherapy in mesothelin-expressing human ovarian cancer models
P2860
Correlation Between Tumor Mesothelin Expression and Serum Mesothelin in Patients with Epithelial Ovarian Carcinoma: A Potential Noninvasive Biomarker for Mesothelin-targeted Therapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Correlation Between Tumor Meso ...... r Mesothelin-targeted Therapy.
@en
type
label
Correlation Between Tumor Meso ...... r Mesothelin-targeted Therapy.
@en
prefLabel
Correlation Between Tumor Meso ...... r Mesothelin-targeted Therapy.
@en
P2093
P2860
P1476
Correlation Between Tumor Meso ...... r Mesothelin-targeted Therapy.
@en
P2093
Akira Kurosaki
Hiroyuki Seki
Keiichi Fujiwara
Kosei Hasegawa
Masanori Yasuda
Shoji Nagao
Tatsuya Hanaoka
Tomomi Kato
P2860
P2888
P304
P356
10.1007/S40291-017-0255-2
P50
P577
2017-02-03T00:00:00Z
P6179
1083535072